Veritas Asset Management LLP Sells 206,699 Shares of Elevance Health, Inc. $ELV

08 Sep 2026, 23:30 by Tristan Rich · The Markets Daily

Veritas Asset Management LLP trimmed its holdings in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 32.5% in the 2nd quarter, Holdings Channel.com reports. The firm owned 428,672 shares of the company’s stock after selling 206,699 shares during the period. Elevance Health makes up approximately 3.1% of Veritas Asset Management LLP’s portfolio, making the stock its 15th largest holding. Veritas Asset Management LLP’s holdings in Elevance Health were worth $165,780,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in ELV. Field & Main Bank increased its position in Elevance Health by 1.3% during the 2nd quarter. Field & Main Bank now owns 1,883 shares of the company’s stock valued at $728,000 after buying an additional 25 shares in the last quarter. Tranquilli Financial Advisor LLC boosted its holdings in Elevance Health by 1.3% in the second quarter. Tranquilli Financial Advisor LLC now owns 2,081 shares of the company’s stock worth $805,000 after acquiring an additional 26 shares in the last quarter. WealthCollab LLC grew its stake in shares of Elevance Health by 42.2% in the first quarter. WealthCollab LLC now owns 91 shares of the company’s stock worth $27,000 after acquiring an additional 27 shares during the last quarter. Signet Financial Management LLC grew its stake in shares of Elevance Health by 3.5% in the first quarter. Signet Financial Management LLC now owns 837 shares of the company’s stock worth $245,000 after acquiring an additional 28 shares during the last quarter. Finally, Cornerstone Financial Management LLC increased its holdings in shares of Elevance Health by 12.0% during the second quarter. Cornerstone Financial Management LLC now owns 270 shares of the company’s stock valued at $104,000 after acquiring an additional 29 shares in the last quarter. 89.24% of the stock is owned by institutional investors.

Insider Buying and Selling at Elevance Health

In other Elevance Health news, Director Robert Dixon, Jr. sold 151 shares of the stock in a transaction on Thursday, June 11th. The stock was sold at an average price of $401.77, for a total transaction of $60,667.27. Following the sale, the director owned 10,734 shares of the company’s stock, valued at approximately $4,312,599.18. This trade represents a 1.39% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.34% of the stock is owned by insiders.

Elevance Health Stock Performance

Elevance Health stock traded down $5.46 during midday trading on Tuesday, hitting $402.04. The stock had a trading volume of 1,174,510 shares, compared to its average volume of 1,657,393. The company has a market capitalization of $87.19 billion, a PE ratio of 17.87, a P/E/G ratio of 2.12 and a beta of 0.69. The company has a current ratio of 1.52, a quick ratio of 1.52 and a debt-to-equity ratio of 0.68. The firm’s fifty day moving average is $397.41 and its two-hundred day moving average is $365.53. Elevance Health, Inc. has a 52-week low of $274.84 and a 52-week high of $436.24.

Elevance Health (NYSE:ELV – Get Free Report) last issued its earnings results on Wednesday, July 15th. The company reported $7.45 earnings per share for the quarter, topping analysts’ consensus estimates of $6.21 by $1.24. Elevance Health had a net margin of 2.47% and a return on equity of 14.64%. The firm had revenue of $49.83 billion during the quarter, compared to analyst estimates of $48.88 billion. During the same quarter in the prior year, the business earned $8.84 earnings per share. Elevance Health’s revenue for the quarter was up .8% on a year-over-year basis. On average, research analysts forecast that Elevance Health, Inc. will post 27.18 EPS for the current year.

Elevance Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Thursday, September 10th will be paid a dividend of $1.72 per share. The ex-dividend date is Thursday, September 10th. This represents a $6.88 annualized dividend and a dividend yield of 1.7%. Elevance Health’s dividend payout ratio (DPR) is currently 30.58%.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on ELV shares. Sanford C. Bernstein set a $488.00 price target on shares of Elevance Health in a research note on Thursday, July 16th. Truist Financial lifted their target price on shares of Elevance Health from $450.00 to $475.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Leerink Partners raised their price target on shares of Elevance Health from $364.00 to $395.00 and gave the company a “market perform” rating in a research report on Friday, July 17th. Morgan Stanley boosted their price objective on shares of Elevance Health from $352.00 to $404.00 and gave the stock an “equal weight” rating in a report on Thursday, June 4th. Finally, Raymond James Financial set a $450.00 target price on Elevance Health in a research note on Tuesday, July 7th. Fifteen analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $440.90.

View Our Latest Research Report on Elevance Health

About Elevance Health

(Free Report)

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.